The Outcome of Patients with Severe and Severe-Complicated Clostridium difficile Infection Treated with Tigecycline Combination Therapy: A Retrospective Observational Study.
| Author | |
|---|---|
| Abstract | :
Tigecycline is a third-line therapy for severe Clostridium difficile infection (CDI) in Australasian guidelines. Differences in strain types make it difficult to extrapolate international tigecycline efficacy data with combination or monotherapy to Australian practice, where experience is limited. |
| Year of Publication | :
2018
|
| Journal | :
Internal medicine journal
|
| Date Published | :
2018
|
| ISSN Number | :
1444-0903
|
| URL | :
http://dx.doi.org/10.1111/imj.13742
|
| DOI | :
10.1111/imj.13742
|
| Short Title | :
Intern Med J
|
| Download citation |